申请人:Gruppo Lepetit S.p.A.
公开号:US04435417A1
公开(公告)日:1984-03-06
3H-naphtho[1,2-d]imidazole derivatives of formula ##STR1## wherein R stands for (C.sub.1-6)alkyl, (C.sub.3-6)alkenyl, (C.sub.3-6)alkynyl or (C.sub.3-7)cycloalkyl, R.sub.1 and R.sub.2, each independently may represent hydrogen, halogen, (C.sub.1-4)alkyl, (C.sub.1-4)alkylthio, (C.sub.1-4)alkoxy or halo(C.sub.1-4)alkoxy, R.sub.3 stands for hydrogen, hydroxy, methoxy, ethoxy, or mono- or di-methylamino, and R.sub.4 represents hydrogen or (C.sub.1-4)alkyl. Also described and claimed are their use as antiinflammatory agents and the pharmaceutical compositions containing them.
化合物公式为##STR1## 其中R代表(C.sub.1-6)烷基,(C.sub.3-6)烯基,(C.sub.3-6)炔基或(C.sub.3-7)环烷基,R.sub.1和R.sub.2,各自独立地可以代表氢,卤素,(C.sub.1-4)烷基,(C.sub.1-4)烷基硫醚,(C.sub.1-4)烷氧基或卤代(C.sub.1-4)烷氧基,R.sub.3代表氢,羟基,甲氧基,乙氧基或单甲基或二甲基氨基,R.sub.4代表氢或(C.sub.1-4)烷基。还描述和声明它们作为抗炎药物的用途和含有它们的制药组合物。